Oncology PracticeCabozantinib used as first-line therapy prolongs PFS for metastatic RCCOctober 15, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeAdjuvant sunitinib offers DFS edge in high-risk RCCOctober 14, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeFDA modifies dosage regimen for nivolumabSeptember 19, 2016Lung CancerGenitourinary CancerLymphoma & Plasma Cell DisordersMelanomaRenal Cell Carcinoma
Oncology PracticeDrug combo shows promise for non–clear cell renal cell carcinomaSeptember 6, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeActive surveillance may be feasible for some advanced RCC patientsAugust 12, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeGene profile predicts RCC response to nivolumabAugust 4, 2016Genitourinary CancerImmuno-oncologyRenal Cell Carcinoma
Oncology PracticeFirst-in-class agent shows early promise in treating clear cell renal cell carcinomaJuly 27, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeCabozantinib improves overall survival in renal cell carcinomaJuly 20, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeSU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerHead & Neck/Thyroid CancersMelanomaMultiple MyelomaImmuno-oncologyRenal Cell Carcinoma
Oncology PracticeImmune agonist, checkpoint inhibitor combo shows good tolerabilityJune 15, 2016Genitourinary CancerBreast CancerLung CancerMelanomaRenal Cell Carcinoma
Hematology NewsFDA grants accelerated approval to nivolumab for Hodgkin lymphomaMay 17, 2016Aggressive LymphomasLymphoma & Plasma Cell DisordersRenal Cell CarcinomaHodgkin Lymphoma
Oncology PracticeFDA approves lenvatinib for advanced renal cell carcinomaMay 16, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeImmune checkpoint inhibitors have antitumor activity in gastric, esophageal cancersJanuary 28, 2016GastroenterologyRenal Cell CarcinomaGastrointestinal Cancer
Oncology PracticeIndividualized approach improves surveillance after renal cell carcinoma resectionSeptember 8, 2015Genitourinary CancerRare DiseasesRenal Cell Carcinoma
Oncology PracticeNivolumab benefits patients with previously treated renal cell carcinomaMarch 23, 2015GastroenterologyRenal Cell CarcinomaGastrointestinal Cancer
